MRNA vs. VMW

Last updated Jun 13, 2026

MRNA (Moderna, Inc.) and VMW (VMware, Inc.) are both stocks. MRNA operates in Biotechnology (Healthcare), while VMW operates in Software - Infrastructure (Technology). At a 0.17 correlation, their price movements are largely independent.

Performance

MRNA vs. VMW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Moderna, Inc. (MRNA) and VMware, Inc. (VMW). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

MRNA

• 1D: 0.54%
• 1M: 1.77%
• YTD: 69.24%
• 6M: 69.42%
• 1Y: 87.14%
• 3Y*: -26.94%
• 5Y*: -25.59%
• 10Y*: —

VMW

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

MRNA vs. VMW - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
MRNA Moderna, Inc.	69.24%	-29.08%	-58.19%	-44.63%	-29.28%	143.11%	434.10%	28.09%	-30.59%
VMW VMware, Inc.	0.00%	0.00%	0.00%	16.06%	5.94%	0.72%	-7.60%	10.69%	1.58%

Correlation

The correlation between MRNA and VMW is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	0.07
Correlation (5Y) Calculated over the trailing 5-year period	0.18
Correlation (All Time) Calculated using the full available price history since Dec 7, 2018	0.17

The correlation between MRNA and VMW shifts across timeframes, from 0.07 (3 years) to 0.18 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Total Revenue (TTM) MRNA : $2.23B VMW : $13.61B
Gross Profit (TTM) MRNA : -$309.00M VMW : $11.05B
EBITDA (TTM) MRNA : -$3.02B VMW : $2.61B

Return for Risk

MRNA vs. VMW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRNA

MRNA Risk / Return Rank: 78
MRNA Sharpe Ratio Rank: 80
MRNA Sortino Ratio Rank: 79
MRNA Omega Ratio Rank: 75
MRNA Calmar Ratio Rank: 79
MRNA Martin Ratio Rank: 76

VMW

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRNA vs. VMW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Moderna, Inc. (MRNA) and VMware, Inc. (VMW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	MRNA	VMW	Difference
Sharpe ratio: Return per unit of total volatility	1.28	—	—
Sortino ratio: Return per unit of downside risk	2.13	—	—
Omega ratio: Gain probability vs. loss probability	1.24	—	—
Calmar ratio: Return relative to maximum drawdown	2.34	—	—
Martin ratio: Return relative to average drawdown	4.59	—	—

Drawdowns

Drawdown Indicators

	MRNA	VMW	Difference
Max Drawdown Largest peak-to-trough decline	-95.38%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-35.51%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-86.58%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-95.38%	—	—
Current Drawdown Current decline from peak	-89.70%	—	—
Average Drawdown Average peak-to-trough decline	-57.06%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	18.06%	—	—

Volatility

Volatility by Period

	MRNA	VMW	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.56%	—	—
Volatility (6M) Calculated over the trailing 6-month period	48.82%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	64.75%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	66.49%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	72.15%	—	—

Dividends

MRNA vs. VMW - Dividend Comparison

Neither MRNA nor VMW has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
MRNA Moderna, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VMW VMware, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	23.65%	0.00%	0.00%	19.55%

Financials

Frequently Asked Questions

Can I hold both MRNA and VMW in my portfolio?

MRNA and VMW have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.